A Breakthrough in Pancreatic Cancer Treatment
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for pancreatic cancer, one of the deadliest cancers with limited therapeutic options.
Related Articles
A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite–CerS6–ceramide axis
The gut microbiota is known to be associated with a variety of human metabolic diseases, including metabolic dysfunction–associated steatohepatitis (MASH). Fungi are increasingly recognized as…
Could This Toxin Be Behind the Rise of Early Onset Colon Cancer?
It’s still not clear why colon cancer cases continue to rise among young people — but researchers may have come across a lead. A new…
HHS, NIH launch next-generation universal vaccine platform for
These vaccines aim to provide broad-spectrum protection against multiple strains of multiple viruses.
NOT-OD-25-101: Revision: Notice of Updated Effective Date for the 2024 NIH Public Access Policy
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Revision: Notice of Updated Effective Date for the 2024 NIH Public Access…
Institute for Cell Therapy Discovery & Innovation
We are in a pivotal moment in the field of cell therapy. Advances in technologies, the promise of artificial intelligence and our deeper understanding of…
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers
Background We conducted an integrated cross-species spatial assessment of transcriptomic and metabolomic alterations associated with progression of intraductal papillary mucinous neoplasms (IPMNs), which are bona…
Deep Visual Proteomics defines single-cell identity and heterogeneity
Nature Biotechnology – Deep Visual Proteomics combines machine learning, automated image analysis and single-cell proteomics.
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers
Background We conducted an integrated cross-species spatial assessment of transcriptomic and metabolomic alterations associated with progression of intraductal papillary mucinous neoplasms (IPMNs), which are bona…
GEO Accession viewer
NCBI’s Gene Expression Omnibus (GEO) is a public archive and resource for gene expression data.
nuclei.io
Our digital pathology AI framework “nuclei.io” is designed to innovate pathology diagnosis with artificial intelligence and machine learning. By providing real-time single nucleus & tissue-level…